Advertisement

Ulcerated Lesions of the Oral Mucosa: Clinical and Histologic Review

  • Sarah G. FitzpatrickEmail author
  • Donald M. Cohen
  • Ashley N. Clark
Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

Abstract

Ulcerated lesions of the oral cavity have many underlying etiologic factors, most commonly infection, immune related, traumatic, or neoplastic. A detailed patient history is critical in assessing ulcerative oral lesions and should include a complete medical and medication history; whether an inciting or triggering trauma, condition, or medication can be identified; the length of time the lesion has been present; the frequency of episodes in recurrent cases; the presence or absence of pain; and the growth of the lesion over time. For multiple or recurrent lesions the presence or history of ulcers on the skin, genital areas, or eyes should be evaluated along with any accompanying systemic symptoms such as fever, arthritis, or other signs of underlying systemic disease. Biopsy may be indicated in many ulcerative lesions of the oral cavity although some are more suitable for clinical diagnosis. Neoplastic ulcerated lesions are notorious in the oral cavity for their ability to mimic benign ulcerative lesions, highlighting the essential nature of biopsy to establish a diagnosis in cases that are not clinically identifiable or do not respond as expected to treatment. Adjunctive tests may be required for final diagnosis of some ulcerated lesions especially autoimmune lesions. Laboratory tests or evaluation to rule out systemic disease may be also required for recurrent or severe ulcerations especially when accompanied by other symptoms. This discussion will describe the clinical and histopathologic characteristics of a variety of ulcerated lesions found in the oral cavity.

Keywords

Oral ulcer Herpetic gingivostomatitis Aphthous stomatitis Oral erythema multiforme Oral medication related ulcer Oral lichen planus Oral vesiculobullous lesions Traumatic oral ulcer Oral squamous cell carcinoma Oral lymphoma 

Notes

Compliance with Ethical Standards

Conflict of interest

All authors declare no conflicts of interests.

Ethics Approval

This article does not contain any studies with human participants or animal performed by any of the authors.

Informed Consent

Not applicable for this article.

References

  1. 1.
    Leão JC, Gueiros LA, Porter SR. Oral manifestations of syphilis. Clinics. 2006;61:161–6.Google Scholar
  2. 2.
    Alam F, Argiriadou AS, Hodgson TA, et al. Primary syphilis remains a cause of oral ulceration. Br Dent J. 2000;189:352–4.Google Scholar
  3. 3.
    Little JW. Syphilis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:3–9.Google Scholar
  4. 4.
    Stewart RJ, Tsang CA, Pratt RH, et al. Tuberculosis —United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:317–23.Google Scholar
  5. 5.
    Krawiecka E, Szponar E. Tuberculosis of the oral cavity: an uncommon but still a live issue. Adv Dermatol Allergol. 2015;32(4):302–6.Google Scholar
  6. 6.
    Yepes JF, Sullivan J, Pinto A. Tuberculosis: medical management update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:267–73.Google Scholar
  7. 7.
    Whitley RJ, Kimberlin DW, Roizman B. Herpex simplex virus. Clin Infect Dis. 1998;26:541–55.Google Scholar
  8. 8.
    Clarkson E, Mashkoor F, Abdulateef S. Oral viral infections: diagnosis and management. Dent Clin N Am. 2017;61:351–63.Google Scholar
  9. 9.
    Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect. 2006;12:202–11.Google Scholar
  10. 10.
    Baringer JR, Swoveland P. Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med. 1973;288:648–50.Google Scholar
  11. 11.
    Weathers DR, Griffin JW. Intraoral ulceratipons of recurrent herpes simplex and recurrent aphthae: two distinct clinical entities. J Am Dent Assoc. 1970;81:81–8.Google Scholar
  12. 12.
    Cohen SG, Greenberg MS. Chronic oral herpes simplex virus infection in immunocompromised patients. Oral Surg Oral Med Oral Pathol. 1985;59:465–71.Google Scholar
  13. 13.
    Amir J. Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis. Paediatr Drugs. 2001;3:593–7.Google Scholar
  14. 14.
    Arduino PG, Porder SR. Oral and perioral herpes simples virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12:254–70.Google Scholar
  15. 15.
    Jensen LA, Hoehns JD, Squires CL. Oral antivirals for the acute treatment of recurrent herpes labialis. Ann Pharmacother. 2004;38:705–9.Google Scholar
  16. 16.
    Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:12–8.Google Scholar
  17. 17.
    Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9:361–81.Google Scholar
  18. 18.
    Badger GR. Oral signs of chickenpox (varicella): report of two cases. J Dent Child. 1980;47:349–51.Google Scholar
  19. 19.
    Kolokotronis A, Louloudiadis K, Fotiou G, et al. Oral manifestations of infections due to varicella zoster virus in otherwise healthy children. J Clin Pediatr Dent. 2001;25:107–12.Google Scholar
  20. 20.
    Carmichael JK. Treatment of herpes zoster and postherpetic neuralgia. Am Fam Physician. 1991;44:203–10.Google Scholar
  21. 21.
    Tidwell E, Hutson B, Burkhart N, et al. Herpes zoster of the trigeminal nerve third branch: a case report and review of the literature. Int Endod J. 1999;32:61–6.Google Scholar
  22. 22.
    Verbin RS, Heineman HS, Stiff RH. Localized odontalgia occurring during herpes zoster of the maxillary division of the fifth cranial nerve. Report of a case. Oral Surg Oral Med Oral Pathol. 1968;26:441–5.Google Scholar
  23. 23.
    Wood M. Understanding Pain in Herpes Zoster: An Essential for Optimizing Treatment. J Infect Dis. 2002;186:78–82.Google Scholar
  24. 24.
    Straus SE, Ostrove JM, Inchauspe G, et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment and prevention. Ann Intern Med. 1988;108:221–37.Google Scholar
  25. 25.
    Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician. 2000;61:2437–48.Google Scholar
  26. 26.
    Wutzler P. Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology. 1997;40:343–56.Google Scholar
  27. 27.
    Ueda T, Ogata H, Kojima Y, et al. Cytomegalovirus oral ulcers. Infection. 2014;42:235.Google Scholar
  28. 28.
    Dioguardi M, Troiano G, Russo LL, et al. Occult co-infection in the oral cavity with cytomegalovirus during immuno-suppression. J Transl Sci. 2015;1(2):26–8.Google Scholar
  29. 29.
    Jones AC, Freedman PD, Phelan JA, et al. Cytomegalovirus infections of the oral cavity: a report of six cases and review of the literature. Oral Surf Oral Med Oral Pathol. 1993;75:76–85.Google Scholar
  30. 30.
    Sharland M, Khare MD. Cytomegalovirus treatment options in immunocompromised patients. Expert Opin Pharmacother. 2001;2(8):1247–57.Google Scholar
  31. 31.
    Lakshman P, Samaranayake P, Keung Leung W, et al. Oral mucosal fungal infections. Periodontol 2000. 2009;49:39–59.Google Scholar
  32. 32.
    Napoli AJ, Donegan JO. Aspergillosis and necrosis of the maxilla: a case report. J Oral Maxillofac Surg. 1991;49:532–4.Google Scholar
  33. 33.
    Bell WA, Gamble J, Garrington GE. North American blastomycosis with oral lesions. Oral Surg Oral Med Oral Pathol. 1969;28:914–23.Google Scholar
  34. 34.
    Page LR, Drummond JF, Daniels HT, et al. Blastomycosis with oral lesions. Report of two cases. Oral Surg Oral Med Oral Pathol. 1979;47:157–60.Google Scholar
  35. 35.
    Ferreira OG, Cardoso SV, Borges AS, et al. Oral histoplasmosis in Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(6):654–9.Google Scholar
  36. 36.
    Rodriguez RA, Konuia T. Coccidioidomycosis of the tongue. Arch Pathol Lab Med. 2005;129:4–6.Google Scholar
  37. 37.
    Hay RJ. Overview of the treatment of disseminated fungal infections. J Antimicrob Chemother. 1991;28:17–25.Google Scholar
  38. 38.
    Lortholary O, Denning DW, Dupont B. Endemic mycoses: a treatment update. J Antimicrob Chemother. 1999;43:321–31.Google Scholar
  39. 39.
    Shah K, Guarderas J, Krishnaswamy G. Aphthous stomatitis. Ann Allergy Asthma Immunol. 2016;117:e341–3.Google Scholar
  40. 40.
    Shim YJ, Choi JH, Ahn HJ, Kwon JS. Effect of sodium lauryl sulfate on recurrent aphthous stomatitis: a randomized controlled clinical trial. Oral Dis. 2012;18(7):655–60.Google Scholar
  41. 41.
    Gomes CC, Gomez RS, Zina LG, Amaral FR. Recurrent aphthous stomatitis and Helicobacter pylori. Med Oral Patol Oral Cir Bucal. 2016;21(2):e187-91.Google Scholar
  42. 42.
    Miziara ID, Auaujo-Filho BC, Weber R. AIDS and recurrent aphthous stomatitis. Rev Bras Otorhinolaringol. 2005;71(4):517–20.Google Scholar
  43. 43.
    Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: part 1: Crohn’s disease. Br Dent J. 2016;221(12):794–9.Google Scholar
  44. 44.
    Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: part 2: Ulcerative colitis. Br Dent J. 2017;222(1):53–7.Google Scholar
  45. 45.
    Macho VMP, Coelho AS, Veloso e Silva DM, de Andrade DJC. Oral manifestations in pediatric patients with coeliac disease: a review article. Open Dent J. 2017;11:539–45.Google Scholar
  46. 46.
    Cantekin K, Arslan D, Delikan E. Presence and distribution of dental enamel defects, recurrent aphthous lesions and dental caries in children with celiac disease. Pak J Med Sci. 2015;31(3):606–9.Google Scholar
  47. 47.
    Bulur I, Onder M. Behçet disease: new aspects. Clin Dermatol. 2017;35:421–34.Google Scholar
  48. 48.
    Pak S, Logemann S, Dee C, Fershko A. Breaking the magic: mouth and genital ulcers with inflamed cartilage syndrome. Cureus. 2017;9(10):e1743.Google Scholar
  49. 49.
    Wu D, Xin J, Liu J, Zhou P. The association between interleukin polymorphism and recurrent aphthous stomatitis: a meta-analysis. Arch Oral Biol. 2018;93:3–11.Google Scholar
  50. 50.
    Vitale A, Orlando I, Lopalco G, Emmi G, Cattalini M, Frediani B, Galeazzi M, Iannone F, Rigante D, Cantarini L. Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome. Clin Exp Rheumatol. 2016;34(6 Suppl 102):77–81.Google Scholar
  51. 51.
    Scully C, MacFadyen E, Campbell A. Oral manifestations in cyclic neutropenia. Br J Oral Surg. 1982;20(2):96–101.Google Scholar
  52. 52.
    Femiano F, Gombos F, Scully C. Sweet’s syndrome: recurrent oral ulceration, pyrexia, thrombophlebitis, and cutaneous lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:324–7.Google Scholar
  53. 53.
    Edgar NR, Saleh D, Miller RA. Recurrent aphthous stomatitis: a review. J Clin Aesthet Dermatol. 2017;10(3):26–36.Google Scholar
  54. 54.
    Maderal AD, Salisbury PL, Jorizzo JL. Desquamative gingivitis: clinical findings and diseases. J Am Acad Dermatol. 2018;78:839–48.Google Scholar
  55. 55.
    Yuan A, Woo S-B. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:35–47.Google Scholar
  56. 56.
    Celentano A, Tovaru S, Yap T, Adamo D, Aria M, Mignogna MD. Oral erythema multiforme: trends and clinical findings of a large retrospective European case series. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:707–16.Google Scholar
  57. 57.
    Heinze A, Tollefson M, Holland KE. Chiu YE. Characteristics of pediatric recurrent erythema multiforme. Pediatr Dermatol. 2018;35:97–103.Google Scholar
  58. 58.
    Webster K, Golbold P. Nicorandil induced oral ulceration. Br Dent J. 2005;198(10):619–21.Google Scholar
  59. 59.
    Müller S. Oral manifestations of dermatologic disease: a focus on lichenoid lesions. Head Neck Pathol. 2011;5:36–40.Google Scholar
  60. 60.
    Müller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30:54–67.Google Scholar
  61. 61.
    Cheng YS, Gould A, Kurago Z, Fantasia J, Müller S. Diagnosis of oral lichen planus: a position paper of the American academy of oral and maxillofacial pathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(3):332–54.Google Scholar
  62. 62.
    Alaizari NA, Al-Maweri SA, Al-Shamiri HM, Shugaa-Addin B. Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Aust Dent J. 2016;61:282–7.Google Scholar
  63. 63.
    Fortuna G, Massimo A, Schiavo JH. Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review. Eur J Clin Pharmacol. 2017;73:1523–37.Google Scholar
  64. 64.
    Fitzpatrick SG, Honda KS, Sattar A, Hirsch SA. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):511–20.Google Scholar
  65. 65.
    Montague LM, Bhattacharyya I, Islam NM, Cohen DM, Fitzpatrick SG. Direct immunofluorescence testing results in cases of premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(6):675–83.Google Scholar
  66. 66.
    Yamanaka Y, Yamashita M, Innocentini LMA, Macedo LD, Chahud F, Ribeiro-Silva A, Roselino AM, Rocha MJA, Motta AC. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions. Am J Dermatopathol. 2018;40:491–7.Google Scholar
  67. 67.
    Jajarm HH, Asadi R, Bardideh E, Shafaee H, Khazaei Y, Emadzadeh M. The effects of photodynamic and low-level laser therapy for treatment of oral lichen planus—a systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2018;23:254–60.Google Scholar
  68. 68.
    Gupta S, Gosh S, Gupta S. Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis. 2017;23:1029–42.Google Scholar
  69. 69.
    Giuliani M, Troiano G, Cordaro M, Corsalini M, Gioco G, Lo Munzio L, Pignatelli P, Lajolo C. Rate of malignant transformation of oral lichen planus: a systematic review. Oral Dis. 2018.  https://doi.org/10.1111/odi.12885.Google Scholar
  70. 70.
    Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res. 2018;66:6–17.Google Scholar
  71. 71.
    Ohki M, Kikuchi S. Nasal, oral, and pharyngolaryngeal manifestations of pemphigus vulgaris: endoscopic ororhinolaryngologic examination. Ear Nose Throat J. 2017;96(3):120–7.Google Scholar
  72. 72.
    Kasperkiewicz M, Ellebrecht CT, Takahashi H, Yamagami J, Zillikens D, Payne AS, Amagai M. Pemphigus. Nat Rev Dis Primers. 2017;3:17026.Google Scholar
  73. 73.
    Hong GH, Khan IR, Shifera AS, Okeagu C, Thorne JE. Incidence and clinical characteristics of ocular involvement in mucous membrane pemphigoid. Ocul Immunol Inflamm. 2018;19:1–5.Google Scholar
  74. 74.
    Bagan J, Jiménez Y, Murillo J, Bagan L. Oral mucous membrane pemphigoid: a clinical study of 100 low-risk cases. Oral Dis. 2018;24:132–4.Google Scholar
  75. 75.
    Maderal AD, Salisbury P, Jorizzo JL. Desquamative gingivitis: diagnosis and treatment. J Am Acad Dermatol. 2018;78(5):851–61.Google Scholar
  76. 76.
    Di Zenzo G, Carrozza M, Chan LS. Urban legend series: mucous membrane pemphigoid. Oral Dis. 2014;20:35–54.Google Scholar
  77. 77.
    Gilvetti C, Porter SR, Fedele S. Traumatic chemical oral ulceration: a case report and review of the literature. Br Dent J. 2010;208(7):297–300.Google Scholar
  78. 78.
    Kang S, Kufta K, Sollecito TP, Panchal N. A treatment algorithm for the management of intraoral burns: a narrative review. Burns. 2018;44:1065–76.Google Scholar
  79. 79.
    Nahlieli O, Eliav E, Shapira Y, Baruchin AM. Central palatal burns associated with the eating of microwaved pizzas. Burns. 1999;25:465–6.Google Scholar
  80. 80.
    Harrison R, Hicklin D. Electronic cigarette explosions involving the oral cavity. J Am Dent Assoc. 2016;147(11):891–6.Google Scholar
  81. 81.
    Cowan D, Ho B, Sykes KJ, Wei JL. Pediatric oral burns: a ten-year review of patient characteristics, etiologies and treatment outcomes. Int J Pediatr Otorhinolaryngol. 2013;77:1325–8.Google Scholar
  82. 82.
    Jainkittivong A, Aneksuk V, Langlais RP. Oral mucosal lesions in denture wearers. Gerodontology. 2010;27:26–32.Google Scholar
  83. 83.
    Carlson DL. Necrotizing sialometaplasia: a practical approach to the diagnosis. Arch Pathol Lab Med. 2009;133(5):692–8.Google Scholar
  84. 84.
    Butler JN, Kobayashi TT. Traumatic ulcerative granuloma with stromal eosinophilia: a malignant-appearing benign lesion. Cutis. 2017;100:E28–31.Google Scholar
  85. 85.
    Shen WR, Chang JY, Wu YC, Cheng SJ, Chen HM, Wang YP. Oral traumatic ulcerative granuloma with stromal eosinophilia: A clinicopathological study of 34 cases. J Formos Med Assoc. 2015;114(9):881–5.Google Scholar
  86. 86.
    Hirschberg A, Amariglio N, Akrish S, Yahalom R, Rosenbaum H, Okon E, Kaplan I. Traumatic Ulcerative granuloma with stromal eosinophilia. A reactive lesion of the oral mucosa. Am J Clin Pathol. 2006;126:522–9.Google Scholar
  87. 87.
    Salisbury CL, Budnick SD, Li S. T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity. Am J Clin Pathol. 2009;132:722–7.Google Scholar
  88. 88.
    Yang EC, Tan MT, Schwarz RA, Richards-Kortum RR, Gillenwater AM, Vigneswaran N. Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:670–81.Google Scholar
  89. 89.
    Porter S, Gueiros LA, Leão JC, Fedele S. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:603–11.Google Scholar
  90. 90.
    Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, Lingen M, Sauk JJ. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:650–69.Google Scholar
  91. 91.
    Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW Jr, Patton LL, Perkins D, Reid BC, Sciubba JJ, Tomar SL, Wyatt AD Jr, Aravamudhan K, Frantsye-Hawley J, Cleveland JL, Meyer DM. American dental association council on scientific affairs expert panel on screening for oral squamous cell carcinomas. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. JADA. 2010;141(5):509–20.Google Scholar
  92. 92.
    Awadallah M, Idle M, Patel K, Kademani D. Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:628–36.Google Scholar
  93. 93.
    Müller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:591–602.Google Scholar
  94. 94.
    Francisconi CF, Caldas RJ, Oliveira Martins LJ, Fischer Rubira CM, da Silva Santos PS. Leukemic oral manifestations and their management. Asian Pac J Cancer Prev. 2016;17(3):911–5.Google Scholar
  95. 95.
    Rosebush MS, Allen CM, Accurso BT, Bajocchi RA, Cordell KG. Oral mycosis fungoides: a report of three cases and review of the literature. Head Neck Pathol. 2018.  https://doi.org/10.1007/s12105-018-0923-5.Google Scholar
  96. 96.
    Swerdlow SH, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. In: World Health Organization classification of tumours. Lyon: IARC; 2016.Google Scholar
  97. 97.
    Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol. 2007;43:4–14.Google Scholar
  98. 98.
    Rodrigo JP, Suarez C, Rinaldo A, Devaney KO, Carbone A, Barnes L, Heffner DK, Ferlito A. Idiopathic midline destructive disease: fact or fiction. Oral Oncol. 2005;41:340–8.Google Scholar
  99. 99.
    Dojcinov SD, Venkataraman MD, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer—a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405–17.Google Scholar
  100. 100.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent post-transplant lymphoproliferative disorder. Am J Surg Pathol. 2014;38:1522–9.Google Scholar
  101. 101.
    McCormack C, Huang Q. EBV1 mucocutaneous ulcer: a new entity of WHO 2017. Blood. 2018;131(17):1993.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Sarah G. Fitzpatrick
    • 1
    Email author
  • Donald M. Cohen
    • 1
  • Ashley N. Clark
    • 2
  1. 1.Department of Oral and Maxillofacial Diagnostic SciencesUniversity of Florida College of DentistryGainesvilleUSA
  2. 2.Department of Diagnostic and Biomedical SciencesUniversity of Texas at Houston Health Science Center School of DentistryHoustonUSA

Personalised recommendations